Verdict
Adamjee Life Assurance Company Limited entered 2026 with a weaker premium base and a much larger unrealised market-valuation loss, yet the profit impact was cushioned by a release in insurance liabilities. Gross premium fell 12.9% year on year and reported net income before insurance expenses fell 36.7%, while profit after tax declined 25.7% to Rs 91.3 million. The quarter was therefore not simply a claims story or an investment-income story: it was a linked movement between asset values, policyholder obligations and shareholder profit. The core concern is softer premium generation alongside heavy claims cash outflow; the stabiliser is that liability remeasurement absorbed much of the market shock. Official Q1 result filing
Company Name: Adamjee Life Assurance Company Limited
Ticker: ALIFE
Reporting period: Three months ended March 31, 2026
Reporting basis: Company-level, unaudited condensed interim financial statements. Profit-and-loss and cash-flow comparisons are against the three months ended March 31, 2025; balance-sheet comparisons are against audited December 31, 2025. The filing reports rupees in thousands; this article converts major amounts into rupees billions or millions for readability. Quarterly financial statements
AlphaGen readings
Alpha QoQ Score: not available for this period.
TTM Performance Score: not available for this period.
3Y Business Perf Score: 60.21.
Sector Leadership Score: 23.2705.
These four readings are AlphaGen model outputs, not company-reported financial figures. An unavailable reading is shown as unavailable rather than estimated; the two available readings should be used as analytical context, not as a substitute for the filed accounts.
Key comparison: current quarter versus prior year
Premium and reported income
Gross premium/contribution revenue was Rs 8.242 billion, compared with Rs 9.467 billion in Q1 2025, a decline of Rs 1.225 billion or 12.9%. After reinsurance and retakaful cessions, net premium/contribution revenue was Rs 8.082 billion versus Rs 9.287 billion, down 13.0%. Investment income was almost unchanged at Rs 2.868 billion against Rs 2.867 billion, but that stability was overwhelmed by a Rs 3.585 billion unrealised fair-value loss, compared with a Rs 353.8 million loss a year earlier. Consequently, the statement’s net-income line fell to Rs 7.652 billion from Rs 12.092 billion, down 36.7%. PSX-filed statement of profit or loss
Benefits, reserves and operating result
Net insurance and takaful benefits rose to Rs 9.754 billion from Rs 7.380 billion, an increase of Rs 2.374 billion or 32.2%. The counterweight was the net change in insurance and takaful liabilities: it contributed a positive Rs 3.571 billion in Q1 2026, versus a negative Rs 3.265 billion in Q1 2025. That Rs 6.836 billion swing is the central accounting bridge in the quarter. After acquisition, administration and other expenses, results from operating activities were Rs 146.2 million, down 27.3% from Rs 201.1 million. Official Q1 result filing
Profit, tax and earnings per share
Income-tax expense declined to Rs 54.9 million from Rs 78.2 million, leaving profit after tax of Rs 91.3 million versus Rs 122.9 million, a 25.7% reduction. Basic and diluted earnings per share were Rs 0.35 against a restated Rs 0.47. The restated comparison is important because the year-end share count rose to 262.5 million from 250 million; comparing against an unadjusted historical EPS would overstate the deterioration. Total comprehensive income was nearly flat at Rs 125.5 million versus Rs 125.9 million because other comprehensive income increased to Rs 34.2 million from Rs 2.9 million. Filed profit, EPS and comprehensive-income statements
What drove the quarter
Premium contraction came before investment volatility
The first weakness appears in premium production. Gross and net premiums declined at essentially the same rate, which means the change was not created by an unusual shift in reinsurance cession. Net cession was Rs 160.2 million, or about 1.9% of gross premium, compared with Rs 180.0 million, also about 1.9%, in the prior-year quarter. Economically, the company started with less new and renewal inflow to spread fixed distribution and administration costs over. The filing does not provide enough product-level detail in the five-page results announcement to assign the decline to a particular channel, so no channel-specific cause should be inferred from the aggregate numbers. Official financial results
The latest full-year context helps explain why the premium line matters. Management reported that 2025 gross premium grew 17.6%, with new regular bancassurance premium up 57.6%, total new regular premium of Rs 4.020 billion and group-life premium of Rs 1.427 billion. The May 2026 corporate briefing described bancassurance as 82% of new business, with direct distribution contributing 18%. Those are management statements about 2025, not explanations of Q1 2026. Still, they show that the next useful disclosure is channel mix: a slowdown in a bank-led channel would have different persistency and acquisition-cost implications from a decline in single-premium or group business. 2025 annual report; FY2025 corporate briefing
The fair-value loss was large, but not a simple shareholder loss
Investment income from profit, return and dividends was stable, and realised gains eased only modestly to Rs 162.1 million from Rs 179.6 million. The sharp change was unrealised fair value: a Rs 3.585 billion loss in Q1 2026 versus Rs 353.8 million in Q1 2025. This is non-cash at recognition and can reverse as market prices change, but it is still economically relevant because it changes the carrying value of invested assets. Adamjee Life held Rs 119.4 billion across equity securities, government securities, debt securities and open-ended mutual funds at March 31, 2026, so even a small percentage movement in the portfolio can dominate quarterly shareholder earnings before liability offsets. Q1 balance sheet and profit statement
AlphaGen inference: the simultaneous fair-value loss and positive liability movement indicate that a substantial part of asset-market volatility passed through the valuation of policyholder obligations rather than landing entirely on shareholder profit. That is typical of unit-linked life business, where policyholder fund values and associated liabilities move with invested assets. The inference is supported by the direction and scale of the two filed lines, but the exact allocation among statutory funds requires the detailed notes and fund statements. Readers should therefore avoid treating the Rs 3.585 billion fair-value loss as if it were comparable to a trading loss at an industrial company. Company’s explanation of unit-linked fund management
Benefits increased and expenses continued to rise
Gross insurance and takaful benefits increased to Rs 9.977 billion from Rs 7.521 billion. Recoveries from reinsurers and retakaful operators rose to Rs 223.2 million from Rs 142.0 million, leaving the 32.2% increase in net benefits. On the cash-flow statement, claims paid were Rs 8.930 billion, up 22.7% from Rs 7.280 billion, while cash premium received declined 5.6% to Rs 8.057 billion. That combination explains why underwriting cash flow moved to a Rs 2.323 billion outflow from a Rs 373.2 million outflow. Higher benefits can reflect maturities, surrenders or claims; the summary filing does not quantify that mix, so attributing the increase to mortality or lapses would be speculation. Official Q1 cash-flow statement
Acquisition expense increased 6.4% to Rs 945.2 million even as net premium fell 13.0%. Marketing and administration expense rose 5.9% to Rs 360.8 million. On a simple basis, acquisition expense equalled about 11.7% of net premium, up from 9.6% a year earlier; administration expense rose to roughly 4.5% from 3.7%. These are not formal regulatory ratios, but they flag weaker cost absorption. The next quarter should show whether Q1 contained timing effects in commissions or whether distribution cost is rising faster than premium production. Filed Q1 expenses
Balance sheet and solvency context
Total assets were Rs 131.905 billion at March 31, 2026, down 2.0% from Rs 134.593 billion at December 31, 2025. Insurance and takaful liabilities declined 2.0% to Rs 121.766 billion from Rs 124.289 billion, consistent with the liability release recorded in profit or loss. Total equity increased 2.0% to Rs 6.460 billion from Rs 6.334 billion because Q1 profit and positive other comprehensive income added Rs 125.5 million. Cash and bank balances rose 9.8% to Rs 7.043 billion. Q1 statement of financial position
The asset mix remains the defining balance-sheet feature. Government securities were Rs 92.843 billion, equity securities Rs 15.134 billion, mutual funds Rs 6.791 billion and debt securities Rs 4.621 billion. Government securities therefore represented roughly 70% of total assets, while the four disclosed investment categories together were about 90%. The portfolio is large because premiums are invested to support long-dated policyholder obligations. For shareholders, the key questions are not just asset growth but asset-liability matching, credit quality, duration, fund performance and how much investment volatility belongs economically to policyholders versus the shareholder fund. Official March 2026 balance sheet
Management’s FY2025 briefing reported an insurer financial-strength rating of AA and year-end fund size of Rs 131.057 billion. The company investor-relations page also describes the rating outlook as stable. Those are management and rating disclosures, not a guarantee of future solvency. The Q1 filing says retained statutory-fund balances include amounts maintained under Section 35 of the Insurance Ordinance and Rule 14 of the Insurance Rules to meet solvency margins. Readers should watch the detailed solvency statement when it becomes available rather than infer capital adequacy from total equity alone. Corporate briefing; Investor-relations page
Cash flow: why the headline needs care
Operating cash flow was a Rs 2.358 billion outflow, versus Rs 375.8 million outflow in Q1 2025. That looks severe in isolation, but insurer cash-flow classification differs from that of a manufacturer. Premiums and claims sit in underwriting cash flow, while purchases and sales of the securities backing policyholder funds sit in investing cash flow. During Q1, investment proceeds were Rs 43.044 billion and investment purchases Rs 42.471 billion; together with Rs 2.313 billion of profit/return received and Rs 175.2 million of dividends, investing activities generated Rs 3.050 billion. The net result across operating, investing and financing activities was a Rs 630.1 million cash inflow, compared with a Rs 2.582 billion outflow a year earlier. Official Q1 cash-flow statement
The practical interpretation is that liquid resources increased because investment cash receipts covered the underwriting deficit. That is not automatically good or bad: insurers routinely rebalance assets as benefits fall due. The signal to monitor is persistence. Repeated claims cash outflow above premium cash inflow could force more asset realisation, while healthy renewal premiums and disciplined matching would make the same quarterly pattern less concerning. No dividend cash payment was recorded in the Q1 2026 cash-flow statement, so the quarter’s liquidity movement was not driven by a shareholder distribution. Filed cash-flow statement
Recurring versus non-recurring drivers
- Recurring pressure: lower premium revenue, higher cash claims and rising acquisition and administration costs affect the operating economics if they persist.
- Market-sensitive item: the Rs 3.585 billion unrealised fair-value loss is non-cash at recognition and may reverse, but it reveals exposure to asset prices.
- Linked accounting offset: the Rs 3.571 billion positive movement in insurance liabilities absorbed much of the asset-valuation shock; its recurrence depends on policyholder fund values and actuarial movements.
- Relatively stable income: investment income excluding fair-value movements was essentially unchanged, providing a recurring income base for the quarter.
- Tax effect: the lower tax charge softened the fall from operating result to profit after tax, but it did not reverse the underlying decline.
What to monitor next
First, watch gross and net premium growth together with product and channel disclosures. A recovery led by regular renewal business would generally be more informative about persistency than a jump driven by single-premium policies. Second, compare cash premiums received with claims paid and track whether underwriting cash flow normalises. Third, follow acquisition expense as a percentage of net premium; the Q1 rise suggests weaker operating leverage. Fourth, separate investment income, realised gains and unrealised fair-value movements rather than treating them as one line.
Fifth, reconcile investment-market movements with changes in insurance liabilities and statutory funds. The net effect on shareholder profit matters more than either gross line alone. Sixth, monitor equity and regulatory solvency disclosures, not just total assets. Seventh, look for management detail on bancassurance, direct agency, group life and Window Takaful, because the aggregate Q1 filing cannot identify which channel caused the premium decline. Finally, compare Q2 and first-half numbers with Q1: a single quarter can be distorted by policy maturities, investment-market moves and commission timing, while a six-month pattern is more diagnostic.
Bottom line
Adamjee Life remained profitable in Q1 2026, and total comprehensive income was broadly unchanged because positive other comprehensive income offset the lower profit after tax. But the operating picture weakened: premiums contracted, benefits and cash claims increased, expense ratios moved higher and reported profit fell. The large unrealised investment loss should be read together with the liability release, not in isolation. The next test is whether premium generation and underwriting cash flow improve while acquisition costs are brought back into line with the premium base. This is financial analysis, not a recommendation to buy or sell the shares.
Sources
- Adamjee Life Q1 2026 condensed interim financial statements
- PSX financial-results filing for the quarter ended March 31, 2026
- Adamjee Life Annual Report 2025
- Adamjee Life FY2025 corporate briefing presentation
- Adamjee Life investor-relations financial information
- Pakistan Stock Exchange company profile and announcement history